Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Axiad ID Cloud Now Certified SAFE-BioPharma Compliant--Biopharmaceutical and Healthcare Organizations Can Now Easily Manage SAFE-BioPharma Compliant Identity Credentials

Axiad ID Cloud has been certified compliant with the SAFE-BioPharma global digital identity and signature standards. Axiad ID Cloud makes it simple for biopharmaceutical and healthcare companies to manage SAFE-BioPharma compliant identity credentials.


News provided by

Axiad IDS, Inc.

Oct 23, 2018, 10:15 ET

Share this article

Share toX

Share this article

Share toX

Axiad IDS provides Trusted Identity and Access Management solutions to enterprise, government and financial organizations  around the world.
Axiad IDS provides Trusted Identity and Access Management solutions to enterprise, government and financial organizations around the world.

SANTA CLARA, Calif., Oct. 23, 2018 /PRNewswire-PRWeb/ -- Axiad IDS, a leading provider of authentication and Trusted Identity solutions for enterprise, healthcare, government and financial organizations, today announced the company's Axiad ID Cloud has been certified compliant with the SAFE-BioPharma® global digital identity and signature standards. Axiad ID Cloud makes it simple for biopharmaceutical and healthcare companies to manage SAFE-BioPharma compliant identity credentials.

"The global biopharmaceutical and healthcare industry is characterized by rapid digitization. Because of the highly personal nature of the data — cybersecurity and identity needs are both unique and complex in this sector," said Monica Nascimento, Vice President, Axiad IDS. "Our SAFE-BioPharma certification is a big deal and particularly important for our healthcare industry clients who need to know we can help them meet critical high-assurance identity trust standards."

“The global biopharmaceutical and healthcare industry is characterized by rapid digitization. Because of the highly personal nature of the data — cybersecurity and identity needs are both unique and complex in this sector,” said Monica Nascimento, Vice President, Axiad IDS.

Post this

The Axiad ID Cloud + SAFE-BioPharma Solution
Axiad IDS' SAFE-BioPharma solution, allows healthcare and biopharmaceutical organizations to manage access to electronic medical records, clinical portals, and application of digital signatures to electronic documents, including those in the cloud. SAFE stands for Signatures & Authentication For Everyone.

With Axiad ID Cloud, organizations can easily issue and manage SAFE-BioPharma smart cards and tokens with PKI certificates for authentication, signature, and encryption –- anytime, anywhere. SAFE-BioPharma certificates can be loaded to any FIPS 140-2 credential or device via the Axiad ID Cloud. And as a virtual private cloud (VPC), there is no co-mingling of data which provides extra layers of security.

Specifically, Axiad ID Cloud provides organizations with a frictionless user experience from the creation and issuance of secure SAFE-BioPharma credentials to the use and full lifecycle management of the credentials.

Creation: Axiad IDS removes the complexity from the process; SAFE-BioPharma compliant credentials can now be created and authenticated in-house from a secure portal. Users no longer need to travel off-site and/or bother with a notary.

Use: With Axiad IDS, SAFE-BioPharma certificates can be loaded directly to a secure token. Unique to Axiad IDS, multiple certificates and credentials — SAFE Bio-Pharma or otherwise — can be loaded to the same token to simplify user requirements.

Lifecycle Management: With Axiad ID Cloud, SAFE BioPharma certificates can be saved directly to user tokens — rather than computers — simplifying the issuance, updating and replacement of secure credentials. All transactions can be conducted from a single secure portal.

Why SAFE-BioPharma?
SAFE-BioPharma standards allow member companies to meet security and confidentiality needs specific to healthcare. Compliance with the standards provides the strongest proof that a person is who they claim to be in a digital environment — this proof is critical in many environments such as submissions to government regulators or access to sensitive health records.

The electronic identities verified by the SAFE-BioPharma standard are highly trustworthy using PKI technology to ensure user and data integrity and non-repudiation by securing the data and information transactions exchanged via the internet.

PKI is a set of policies and procedures to establish a secure information exchange. This ecosystem encompasses not only hardware and software, but all the users involved with the digital certificates that are issued and managed by a Certification Authority (CA).

To learn more about how Axiad IDS can help your organization with its SAFE-BioPharma needs, please visit: https://www.axiadidcloud.com/safebiopharma/. We also invite you to join us for one of two upcoming webinars on our SAFE-BioPharma solution — October 25 and November 6. Please register in advance here. You can also learn more about our solutions by reading our SAFE Bio-Pharma white paper or brochure.

About Axiad IDS
Axiad IDS is a Trusted Identity solutions provider for enterprise, government and financial organizations. Axiad IDS was founded by industry experts with extensive backgrounds in developing, deploying, and managing identity and access management solutions. These experts have experienced first-hand the challenges associated with implementing and managing mission-critical identity systems, and are experienced in overcoming those challenges, enabling their success. Axiad IDS is driven by its customers' business needs, addressing business objectives with innovative and cost-effective solutions. Axiad IDS was founded in 2010 and is headquartered in Santa Clara, CA.

SOURCE Axiad IDS, Inc.

Related Links

www.axiadids.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.